In the overall population, the improvement in PFS did not reach statistical significance (median PFS 5.7 vs. 3.8 months; HR 0.76; p = 0.126) [ 114 ].
← all excerpts
Redefining the Treatment Landscape of Advanced Endometrial Cancer in the Era of Immunotherapy and Precision Oncology.
1
0.1260
0.1260